Navigation Links
IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue
Date:8/1/2013

MOUNTAIN VIEW, Calif., Aug. 1, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2013. 

  • Revenues were $9.2 million in the second quarter of 2013, up from $8.4 million in the prior year comparable period and up sequentially from $8.9 million in the first quarter of 2013.
  • For the second quarter of 2013, operating income was $0.5 million compared with an operating loss of $0.4 million for the second quarter of 2012.
  • Net income from continuing operations was $0.4 million or $0.04 per diluted share for the second quarter of both 2013 and 2012. The second quarter of 2012 benefited from the final $0.8 million payment under a legal settlement that was recorded as part of other income.
  • Gross margin for the second quarter of 2013 was 48.7%, comparable to 48.7% in the prior year period and up from 47.3% in the 2013 first quarter.
  • As anticipated, operating expenses again trended downward in the second quarter of 2013 to $4.0 million compared to $4.5 million in the prior year period.
  • Revenues for the first six months 2013 were $18.1 million, up 8% from last year's first six months.
  • Operating income for the first half of 2013 was $1.4 million, up $2.0 million from last year.
  • Income from continuing operations for the first half of 2013 was $1.3 million compared to $0.1 million for the first half of 2012, or earnings of $0.13 per share compared to $0.01 per share on a diluted basis.
  • Guidance for third quarter: The Company expects to achieve revenue between $8.8 million and $9.1 million, representing growth of between 11% and 15% over the prior year period. Gross margin is anticipated to come in between 47% and 49%, operating expenses between $3.9 million and $4.1 million and the Company anticipates generating operating income.'/>"/>

  • SOURCE IRIDEX Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
    2. IRIDEX Reports 2012 First Quarter Results
    3. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
    4. IRIDEX Reports 2012 Second Quarter Results
    5. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
    6. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
    7. IRIDEX Reports 2012 Third Quarter Results
    8. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
    9. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
    10. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
    11. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... March 27, 2015 The International Myeloma Foundation ... patients while working toward prevention and a cure – ... introducing a federal resolution (H. Res. 174) that supports ... "National Multiple Myeloma Awareness Month." Currently there ... and more than 110,000 new cases are diagnosed yearly, ...
    (Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
    (Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
    Breaking Medicine Technology:The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
    ... SAN DIEGO, Dec. 10, 2010 Arena Pharmaceuticals, Inc. ... of dosing in a Phase 1 clinical trial of ... that targets the prostacyclin receptor for the treatment of ... bioavailable prostacyclin receptor agonist could improve the standard of ...
    ... Dec. 9, 2010 United Seating & Mobility (USM) ... is excited to announce today that it has finalized a ... Business located in Little Rock, Arkansas. Alliance Homecare ... services including oxygen, DME and sleep therapy in the Little ...
    Cached Medicine Technology:Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension 4United Seating & Mobility Reaches Agreement With Alliance Homecare Equipment to Acquire its Complex Mobility Business 2
    (Date:3/27/2015)... Mirada, CA (PRWEB) March 27, 2015 ... physician, Stanley G. Katz, M.D., is now treating knee ... California, including Anaheim , Long Beach, and La ... treatment of acute knee and hip joint disorders as ... Stanley Katz is passionate in returning his patients back ...
    (Date:3/27/2015)... San Jose, CA (PRWEB) March 27, 2015 ... last week’s 2015 GPU technology conference (GTC) , the ... to fight cancer and push the human lifespan well beyond ... Baltimore MD informatics company , is one of 12 ... , While other startups in the GTC Emerging ...
    (Date:3/27/2015)... 2015 On March 19, 2015, ... Detroit Lions wide receiver Herman Moore, hosted “Fighting ... on substance abuse, treatment options and the recent ... were pastors, ministers and bishops from local churches ... guests. , “Our ‘Fighting Addiction Together’ luncheon was ...
    (Date:3/27/2015)... FL and London, UK (PRWEB) March 27, 2015 ... announced today that it has appointed Sean Fitzgerald, a ... role of Chief Operating Officer and Interim Chief Financial ... President of leading education technology innovator, EverFi, backed by ... Schmidt, and Twitter founder Evan Williams. Prior to EverFi, ...
    (Date:3/27/2015)... WA (PRWEB) March 27, 2015 When ... can be hard to know where to begin. The ... experienced Seattle trucking accident attorney, offers accident victims a ... and legal assistance to ensure their personal injury claim ... begins by describing the first actions that should be ...
    Breaking Medicine News(10 mins):Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2
    ... , TUESDAY, Nov. 16 (HealthDay News) -- Men who ... disease, new research suggests. The notion is based on ... a thickening of the men,s neck,s carotid artery wall. Such ... for heart disease. What,s more, the link between sleep ...
    ... TUESDAY, Nov. 16 (HealthDay News) -- A rare, but ... hyperemesis gravidarum, may be hereditary, researchers say. Each ... are hospitalized due to hyperemesis gravidarum (HG), marked by ... cause weight loss, dehydration and psychological trauma. The condition, ...
    ... , TUESDAY, Nov. 16 (HealthDay News) -- Bouts ... behavior over time, including their propensity for more heavy drinking, ... 500 boys in Pittsburgh who were assessed each year from ... four to five years later. When they were teens, ...
    ... Three-year-old Denver resident Brianna,s favorite color was yellow and her ... At 18 months she strapped on her first pair of ... loved playing with her brother and noticed everything. ... from a cardiac arrhythmia known as Long QT Syndrome. Brianna,s ...
    ... N.C. The National Institutes of Health (NIH), National ... Duke University Medical Center up to $52.8 million over ... and oversight of external quality assurance programs that monitor ... around the world. The project, External Quality ...
    ... Nov. 16 (HealthDay News) -- Hospital care-related problems contribute ... month, according to a new federal government study. ... including infections, bed sores and excessive bleeding from blood-thinning ... patients discharged from hospitals in October 2008, USA ...
    Cached Medicine News:Health News:Shorter Sleep in Men Ups Risk of Heart Disease: Study 2Health News:Rare, Severe Form of Morning Sickness Appears to Be Genetic 2Health News:For Teen Boys, Heavy Drinking & Impulsivity May Be Vicious Circle 2Health News:University of Colorado in pilot project to map defibrillators 2Health News:Duke to lead oversight of HIV laboratories worldwide 2Health News:Duke to lead oversight of HIV laboratories worldwide 3Health News:Hospital Care Deadly for Some, U.S. Study Finds 2
    ... achieves optimum lung penetration for maximum therapeutic ... 1.04-1.10 µ at 6-8 LPM. Latex-free components. ... ,As the world leader in airway management ... of proven technology by offering top brands ...
    ... nebulizer the gold standard for continuous medication delivery. ... together in one convenient kit. You asked, and ... HOPE Kit which contains a HOPE nebulizer, 6 ... all in one set up. This kit has ...
    ... offer a spill-proof design and effective output, ... angle. All medical nebulizers are free-standing for ... configurations are available., ,All Portex® medication ... medication nebulizers feature consistently fine misting and ...
    ... everything the health care professional needs to ... efficiently: 7 nebulizers, T-piece and mouthpiece, exhalation ... ,Shipped 5 kits per case., ... ,Intended Use: AsthmaKit is a procedural kit ...
    Medicine Products: